Trials / Completed
CompletedNCT00229177
Study of ONO-2506 in Patients With Acute Ischemic Stroke
Controlled Study of ONO-2506 in Patients With Acute Ischemic Stroke
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 757 (actual)
- Sponsor
- Ono Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the efficacy and safety of ONO-2506 compared to placebo in patients with acute ischemic stroke.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ONO-2506 | Once daily one-hour intravenous infusion at 12/mg/kg/hr for 7 days |
| DRUG | ONO-2506 | Once daily one-hour intravenous infusion at 0 mg/kg/hr for 7 days |
| DRUG | ONO-2506 | Once daily one-hour intravenous infusion at 8 mg/kg/hr for 7 days |
Timeline
- Start date
- 2005-09-01
- Primary completion
- 2008-09-01
- Completion
- 2008-09-01
- First posted
- 2005-09-29
- Last updated
- 2012-06-13
Locations
9 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00229177. Inclusion in this directory is not an endorsement.